<--- Back to Details
First PageDocument Content
Immunosuppressants / Amgen / Etanercept / Tumor necrosis factor-alpha / Biologic / Rheumatoid arthritis / Gene therapy / Vector / Transgene / Biology / Gene delivery / Molecular biology
Date: 2013-12-16 11:01:39
Immunosuppressants
Amgen
Etanercept
Tumor necrosis factor-alpha
Biologic
Rheumatoid arthritis
Gene therapy
Vector
Transgene
Biology
Gene delivery
Molecular biology

PROTOCOL 588: OVERALL ASSESSMENT • • • •

Add to Reading List

Source URL: osp.od.nih.gov

Download Document from Source Website

File Size: 22,97 KB

Share Document on Facebook

Similar Documents

Amgen-Scholars-US Program-OCT2016

DocID: 1vl38 - View Document

Amgen-Scholars-Program-Japan-Translated-OCT2016

DocID: 1v8Op - View Document

Amgen-Scholars-Program-Japan-Translated-OCT2016

DocID: 1uS7i - View Document

Student Guide Amgen Scholars Programme Ludwig-Maximilians University Munich Undergraduate Summer Research 2018 European LMU Amgen Scholars Programme

DocID: 1uMs7 - View Document

Amgen-Scholars-Japan-Program-A4-OCT2016

DocID: 1uKFN - View Document